Systematically evaluate difficult-to-control asthma
Identify specific severe asthma phenotypes/endotypes
Utilize novel asthma therapeutics with confidence
Assessment and management of severe asthma are at the forefront of modern asthma investigation and care. This two-day, hybrid course will provide insights from a multidisciplinary team representing the Severe Asthma Program at Brigham and Women’s Hospital. Our focus will include both pediatric and adult patients with asthma. We will devote one day to assessment of severe asthma and complicating illnesses. Lectures will cover topics in the immunology and genetics of severe asthma; aspirin-exacerbated respiratory disease; allergic bronchopulmonary aspergillosis and eosinophilic granulomatosis with polyangiitis; occupational asthma; obesity and asthma; and special considerations in school-age children. Presentations on the contribution of gastroesophageal reflux disease, vocal fold movement disorder and chronic rhinosinusitis/nasal polyposis will be given by a gastroenterologist, voice specialist and otolaryngologists, respectively. Discussion will include consideration of mimics of asthma in children and adults and explore the possibility of the primary prevention of asthma. A full day will be devoted to the treatment of severe asthma in children and adults, including recent GINA and NAEPP guidelines; modern biologics; and novel therapies in development. We will devote time to interactive case discussions regarding patients with severe asthma presenting both diagnostic and therapeutic challenges. This course is appropriate for allergists, pulmonologists and other specialists with an interest in the management of severe asthma.
This accredited course is offered by Brigham and Women's Hospital. This course is targeted to Primary Care Physicians, Specialty Physicians, Pulmonary Medicine, Allergy and Immunology and Otolaryngology. Contact ceprograms@hms.harvard.edu with questions.
*Register before February 23, 2023 to receive the discounted price.
